Mark Garzotto

Improved Detection of Prostate Cancer Using Classification and Regression Tree Analysis

Mark Garzotto, Tomasz M. Beer, Rebekah Hudson et al. · Journal of Clinical Oncology · 2005 · 121 citations

Medicine, Oncology, Urology +17

Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.

Jie Dai, R Shen, Makoto Sumitomo et al. · PubMed · 2001 · 59 citations

Medicine, Biochemistry, Oncology +10

Phase 1/2 study of preoperative docetaxel and mitoxantrone for high‐risk prostate cancer

Mark Garzotto, Celestia S. Higano, Catherine O′Brien et al. · Cancer · 2010 · 38 citations

Medicine, Oncology, Pharmacology +17

Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer

Jonathan Q. Purnell, Lisa B. Bland, Mark Garzotto et al. · Journal of Lipid Research · 2005 · 26 citations · Full text

Medicine, Endocrinology, Urology +13

A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521).

Howard M. Sandler, Chen Hu, Seth A. Rosenthal et al. · Journal of Clinical Oncology · 2015 · 21 citations

Medicine, Oncology, Urology +16